Mironid's Series A Round

Mironid raised a round of funding on June 20, 2016.

Mironid is an innovative drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key phosphodiesterase 4 (PDE4) enzymes.…

Articles about Mironid's Series A Round: